Sector: Technology | Industry: IT Services & Consulting |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 1750 Presidents Street RESTON VA 20190 |
Tel: | N/A |
Website: | https://www.leidos.com |
IR: | See website |
Key People | ||
Thomas A. Bell Chief Executive Officer, Director | Gerald A. Fasano Executive Vice President, Chief Growth Officer | Christopher R. Cage Chief Financial Officer, Executive Vice President |
Steve Cook Group President - Dynetics Group | Cindy Gruensfelder President - Defense System Sector | Steve Hull President - Digital Modernization Sector |
Elizabeth A. Porter President - Health and Civil Sector | Mary Victoria Schmanske President - Commercial and International Sector | Roy Stevens President - National Security Sector | Maureen Waterston Chief Human Resource Officer |
Business Overview |
Leidos Holdings, Inc. is a holding company, which operates through its subsidiary, Leidos, Inc. The Company is engaged in developing smarter technology solutions, particularly for customers in highly regulated industries. Its segments include Defense Solutions, Civil and Health. Its Defense Solutions segment provides technologically advanced services, solutions and products to a customer base. Its technologies cover a spectrum of markets with primary areas of concentration in digital modernization, mission systems and integration, command, control, computers, communications, intelligence, surveillance and reconnaissance (C4ISR) technologies and services. Its Civil segment is focused on modernizing infrastructure, systems and security for government and commercial customers both domestically and internationally. Its Health segment delivers effective and affordable solutions to federal and commercial customers that are responsible for the health and well-being of people worldwide. |
Financial Overview |
For the fiscal year ended 29 December 2023, Leidos Holdings Inc revenues increased 7% to $15.44B. Net income decreased 71% to $199M. Revenues reflect Defense Solutions segment increase of 6% to $8.73B, Health segment increase of 13% to $3.04B, Civil segment increase of 6% to $3.66B, United States segment increase of 7% to $14.02B, International segment increase of 11% to $1.32B. |
Employees: | 47,000 as of Dec 29, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $21,310M as of Dec 29, 2023 |
Annual revenue (TTM): | $15,438M as of Dec 29, 2023 |
EBITDA (TTM): | $1,633M as of Dec 29, 2023 |
Net annual income (TTM): | $199.00M as of Dec 29, 2023 |
Free cash flow (TTM): | $757.00M as of Dec 29, 2023 |
Net Debt Last Fiscal Year: | $3,905M as of Dec 29, 2023 |
Shares outstanding: | 135,025,976 as of Mar 6, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |